• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P) Back to Search Results
Model Number V173
Device Problems Premature Discharge of Battery (1057); Pacing Problem (1439); Pocket Stimulation (1463); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Bradycardia (1751); Nausea (1970); Dizziness (2194); No Code Available (3191)
Event Date 01/10/2021
Event Type  Injury  
Event Description
It was reported that the patient with this cardiac resynchronization therapy pacemaker (crt-p) presented to the emergency room with dizziness, nausea, light-headedness and pocket stimulation.The device was interrogated and found to be in safety mode.The patient symptoms were noted to be due to pacing inhibition.It was unknown if the patient had any medical procedures that might have caused the change to safety mode.Subsequently, the patient underwent a revision procedure and this device was explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy pacemaker (crt-p) presented to the emergency room with dizziness, nausea, light-headedness and pocket stimulation.The device was interrogated and found to be in safety mode.The patient symptoms were noted to be due to pacing inhibition.It was unknown if the patient had any medical procedures that might have caused the change to safety mode.Subsequently, the patient underwent a revision procedure and this device was explanted and replaced.No additional adverse patient effects were reported.Additional information was received from the health care professional suspecting premature battery depletion.The cardiac resynchronization therapy pacemaker hit elective replacement indicator and the clinic never got an alert.The patient presented to the hospital two days after this.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The device has been returned for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy pacemaker (crt-p) presented to the emergency room with dizziness, nausea, light-headedness and pocket stimulation.The device was interrogated and found to be in safety mode.The patient symptoms were noted to be due to pacing inhibition.It was unknown if the patient had any medical procedures that might have caused the change to safety mode.Subsequently, the patient underwent a revision procedure and this device was explanted and replaced.No additional adverse patient effects were reported.Additional information was received from the health care professional suspecting premature battery depletion.The cardiac resynchronization therapy pacemaker hit elective replacement indicator and the clinic never got an alert.The patient presented to the hospital two days after this.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode due to system resets.It was confirmed that brady therapy remained available.The system resets occurred during a telemetry session and caused the device to enter safety mode.Engineers determined that this device was demonstrating behavior consistent with a high internal cell impedance within the battery.The high internal impedance resulted in the system resets due to temporary high-power consumption related to telemetry attempts and subsequent reversion to safety mode operation.Boston scientific has issued a field safety notice regarding ingenio extended life (el) and cardiac resynchronization therapy pacemaker (crt-p) devices that may exhibit this behavior.This particular device is included in the high impedance in ingenio extended life (el) pacemaker and crt-p advisory population.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11227922
MDR Text Key241236452
Report Number2124215-2021-01771
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526536632
UDI-Public00802526536632
Combination Product (y/n)N
PMA/PMN Number
P030005/S079
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 10/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/11/2016
Device Model NumberV173
Device Catalogue NumberV173
Device Lot Number105383
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/25/2021
Initial Date Manufacturer Received 01/12/2021
Initial Date FDA Received01/25/2021
Supplement Dates Manufacturer Received01/26/2021
09/28/2021
Supplement Dates FDA Received02/21/2021
10/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
-
-